{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:10:42Z","timestamp":1775031042917,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,11,4]],"date-time":"2004-11-04T00:00:00Z","timestamp":1099526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1007\/s00280-004-0858-2","type":"journal-article","created":{"date-parts":[[2004,11,3]],"date-time":"2004-11-03T16:31:06Z","timestamp":1099499466000},"page":"244-250","source":"Crossref","is-referenced-by-count":19,"title":["Particular cutaneous side effects with etoposide-containing courses: is VP16 or etoposide phosphate responsible?"],"prefix":"10.1007","volume":"55","author":[{"given":"Katel","family":"Marigny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne","family":"Aubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwenola","family":"Burgot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edouard","family":"Le Gall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Gandemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,11,4]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/096032719901800103","volume":"18","author":"Amantea","year":"1999","unstructured":"Amantea M, Newman M, Sullivan T, et al (1999) Relationship of dose intensity to the induction of palmar?plantar erythrodysesthia by pegylated liposomal doxorubicin in dogs. Hum Exp Toxicol 18:17?26","journal-title":"Hum Exp Toxicol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0190-9622(91)70073-B","volume":"24","author":"Baack","year":"1991","unstructured":"Baack B, Burgdorf W (1991) Chemotherapy-induced acral erythema. J Am Acad Dermatol 24:457?461","journal-title":"J Am Acad Dermatol"},{"key":"CR3","first-page":"108","volume":"45","author":"Beijnen","year":"1991","unstructured":"Beijnen J, Beijnen-Bandhoe A, Dubbelman A, et al (1991) Chemical and physical stability of etoposide and teniposide in commonly used infusion fluids. J Parenter Sci Technol 45:108?112","journal-title":"J Parenter Sci Technol"},{"key":"CR4","first-page":"491","volume":"10","author":"Beyer","year":"1992","unstructured":"Beyer J, Grabbe J, Lenz K, et al (1992) Cutaneous toxicity of high-dose carboplatin, etoposide and ifosfamide followed by autologous stem cell reinfusion. Bone Marrow Transplant 10:491?494","journal-title":"Bone Marrow Transplant"},{"key":"CR5","unstructured":"Breathnach S, Hintner H (1993) Antitumoraux. In: Arnette SA (ed) R\u00e9action cutan\u00e9es medicamenteuses. Paris, pp 281?304"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1046\/j.1365-2133.1999.03085.x","volume":"141","author":"Burova","year":"1999","unstructured":"Burova K, Bansal D (1999) Skin eruption to generic prednisolone. Br J Dermatol 141:597?598","journal-title":"Br J Dermatol"},{"key":"CR7","unstructured":"Collectif (1995) M\u00e9dicaments anti-canc\u00e9reux. De la pr\u00e9paration \u00e0 l?administration, optimisation. APHIF, Paris"},{"key":"CR8","unstructured":"Collectif (1999) Liste des excipients \u00e0 effet notoire. Fr\u00e9quence CNHIM 3:1?4"},{"key":"CR9","first-page":"219","volume":"120","author":"Dechauffour","year":"1993","unstructured":"Dechauffour F, Dompmartin A, Troussard X, et al (1993) Eryth\u00e8me acral apr\u00e8s greffe de mo\u00eblle osseuse allog\u00e9nique. Ann Dermatol Venereol 120:219?222","journal-title":"Ann Dermatol Venereol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00000421-199410000-00005","volume":"17","author":"DeSouza","year":"1994","unstructured":"DeSouza P, Friedlander M, Wilde C, et al (1994) Hypersensitivity reactions to etoposide. Am J Clin Oncol 17:387?389","journal-title":"Am J Clin Oncol"},{"key":"CR11","unstructured":"Hardman J, Limbird L, Molinoff P, et al (1996) Les bases pharmacologiques de l?utilisation des m\u00e9dicaments (\u00e9dition fran\u00e7aise 1998). McGraw-Hill, New York"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1528-1157.1979.tb04778.x","volume":"20","author":"Lockard","year":"1979","unstructured":"Lockard J, Levy R, Congdon W, DuCharme L (1979) Efficacy and toxicity of the solvent polyethylene glycol 400 in monkey model. Epilepsia 20:77?84","journal-title":"Epilepsia"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/archderm.136.12.1475","volume":"136","author":"Lotem","year":"2000","unstructured":"Lotem M, Hubert A, Lyass O, et al (2000) Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin. Arch Dermatol 136:1475?1480","journal-title":"Arch Dermatol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/BF01983649","volume":"16","author":"Masini","year":"1985","unstructured":"Masini E, Planchenault J, Pezziardi F, Gautier P (1985) Histamine-releasing properties of polysorbate 80 in vitro and in vivo: correlation with its hypotensive action in the dog. Agents Actions 16:470?477","journal-title":"Agents Actions"},{"key":"CR15","first-page":"566","volume":"44","author":"Montaguti","year":"1994","unstructured":"Montaguti P, Melloni E, Cavalletti E (1994) Acute intravenous toxicity of dimethyl sulfoxide, polyethylene glycol 400, dimethylformamide, absolute ethanol and benzyl alcohol in inbred mouse strains. Arzneimittelforschung 44:566?570","journal-title":"Arzneimittelforschung"},{"key":"CR16","first-page":"959","volume":"68","author":"O?Dwyer","year":"1984","unstructured":"O?Dwyer P, Weiss R (1984) Hypersensitivity reactions induced by etoposide. Cancer Treat Rep 68:959?961","journal-title":"Cancer Treat Rep"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0140-6736(91)92697-Z","volume":"337","author":"P\u00f6nnighaus","year":"1991","unstructured":"P\u00f6nnighaus J, Fine P, Moreno C (1991) Hypersensitivity to dextran in BCG vaccine. Lancet 337:1039","journal-title":"Lancet"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00685939","volume":"34","author":"Portal","year":"1994","unstructured":"Portal I, Cardenal F, Garcia-del-Muro X (1994) Etoposide-related acral erythema. Cancer Chemother Pharmacol 34:181","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0190-9622(96)90725-2","volume":"35","author":"Prussick","year":"1996","unstructured":"Prussick R, Horn T, Wilson W, Turner M (1996) A characteristic eruption associated with ifosfamide, carboplatin and etoposide chemotherapy after pretreatment with recombinant interleukin-1 alpha. J Am Acad Dermatol 35:705?709","journal-title":"J Am Acad Dermatol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0268-960X(05)80021-9","volume":"7","author":"Salmon","year":"1993","unstructured":"Salmon J, Mythen M (1993) Pharmacology and physiology of colloids. Blood Rev 7:114?120","journal-title":"Blood Rev"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1007\/BF00684865","volume":"34","author":"Schacter","year":"1994","unstructured":"Schacter L, Igwemezie L, Seyedsadr M, et al (1994) Clinical and pharmacokinetic overview of parenteral etoposide phosphate. Cancer Chemother Pharmacol [Suppl] 34:S58?S63","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR22","unstructured":"Schorderet M (1998) Pharmacologie, des concepts fondamentaux aux applications th\u00e9rapeutiques. Frison-Roche, Paris"},{"key":"CR23","first-page":"5","volume":"51","author":"St\u00e4helin","year":"1991","unstructured":"St\u00e4helin H, VonWarburg A (1991) The chemical and biological route from podophyllotoxin glucoside to etoposide: Ninth Cain Memorial Award Lecture. Cancer Res 51:5?15","journal-title":"Cancer Res"},{"key":"CR24","first-page":"804","volume":"35","author":"Varma","year":"1985","unstructured":"Varma R, Kaushal R, Junnarkar A, et al (1985) Polysorbate 80: a pharmacological study. Arzneimittelforschung 35:804?808","journal-title":"Arzneimittelforschung"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00820727","volume":"18","author":"Witterland","year":"1996","unstructured":"Witterland A, Koks C, Beijnen J (1996) Etoposide phosphate, the water soluble prodrug of etoposide. Pharm World Sci 18:163?170","journal-title":"Pharm World Sci"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1600-0560.1987.tb01532.x","volume":"14","author":"Yokel","year":"1987","unstructured":"Yokel B, Friedman K, Farmer E, Hood A (1987) Cutaneous pathology following etoposide therapy. J Cutan Pathol 14:326?330","journal-title":"J Cutan Pathol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-004-0858-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-004-0858-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-004-0858-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T10:06:08Z","timestamp":1559037968000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-004-0858-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,4]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["858"],"URL":"https:\/\/doi.org\/10.1007\/s00280-004-0858-2","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,4]]}}}